Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAxis Bank 144a Regulatory News (AXBA)

Share Price Information for Axis Bank 144a (AXBA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 40.9145
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 40.9145
AXBA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Purchase of Citibank’s India Consumer Business

30 Mar 2022 13:04

RNS Number : 6260G
Axis Bank Limited
30 March 2022
 

AXIS/CS/CO/697/2021-22

 

March 30, 2022

 

Sub: Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") w.r.t. acquisition of business undertakings

 

Dear Sir/ Madam,

 

Pursuant to Regulation 30 of the SEBI Listing Regulations, we wish to inform that, the board of directors of Axis Bank Limited (Axis Bank) at their meeting held today i.e. March 30, 2022 have approved the purchase of the Citibank's India Consumer Business from Citibank N.A. (acting through its branch in India) ("CBNA") and the NBFC Consumer Business from Citicorp Finance (India) Limited ("CFIL"), as going concerns, without values being assigned to individual assets and liabilities to either business, subject to fulfilment of specific conditions and obtaining requisite approvals. Axis Bank has executed, inter alia, business transfer agreements with CBNA ("CBNA BTA") and CFIL ("CFIL BTA") on March 30, 2022.

 

The information required pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015, is enclosed herewith as Annexure 1. Also, attached as Annexure 2 is the investor presentation and press release capturing further details about the transaction.

 

We wish to inform you that Axis Bank will host a call with analysts and investors on the above matter at 19.00 P.M. (IST) on March 30, 2022.

 

Conference call Dial in information is as follows:

 

Date

30th March 2022

Time

19.00 P.M. ( IST)

Universal Dial-In numbers

+91 22 6280 1253

+91 22 7115 8154

 

International Toll

HongKong : +852 30186877

Singapore : +65 31575746

UK : +44 2034785524

USA : +1 3233868721

International Toll Free

Hong Kong : 800964448

Singapore : 8001012045

UK : 08081011573

USA : 18667462133

Preregistration Link

Diamond Pass Registration (choruscall.in)

 

The above is for your information and records.

 

Thanking you,

Yours faithfully,

For Axis Bank Limited

 

 

Sandeep Poddar

Company Secretary

Encl: As above

 

 

 

 

 

 

 

 

 

 

 

Annexure 1

Disclosure of information pursuant to Regulation 30 of the SEBI Listing Regulations read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9 September 2015.

 

S. No.

Particulars

Description

1.

Name of the target entity, details in brief such as size, turnover etc.;

1. Citibank N.A. (acting through its branch in India) ("CBNA"): Axis Bank Limited (Axis Bank) proposes to acquire CBNA's entire consumer business in India, including the Credit Cards Business, the Deposits Business, the Wealth Management Business, the Loans Business, the Customer Guarantees Business, the Insurance Distribution Business and the Small Banking Business (collectively the "CBNA Undertaking"), as a going concern, without values being assigned to individual assets and liabilities. The amount of gross revenue of CBNA in India for FY 20-21 was INR 16,15,019 Lacs.[1]

 

2. Citicorp Finance (India) Limited ("CFIL"): Axis Bank proposes to acquire CFIL's consumer business which includes the commercial vehicle and construction equipment asset backed financing facilities, assigned asset backed financing portfolio, personal loans portfolio, servicing of assigned mortgages loan portfolio (collectively the "CFIL Undertaking"), as a going concern, without values being assigned to individual assets and liabilities. The amount of gross revenue of CFIL, on a standalone basis, for FY 20-21 was INR 77,933 Lacs.[2]

2.

Whether the acquisition would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at "arms length"

No, the transactions are not related party transactions.

3.

Industry to which the entity being acquired belongs

The proposed transaction is acquisition of the

CBNA Undertaking from CBNA and CFIL Undertaking from CFIL. Both CBNA and CFIL belong to the Banking and Finance Industry.

4.

Objects and effects of acquisition (including but not limited to, disclosure of reasons for acquisition of target entity, if its business is outside the main line of business of the listed entity)

The acquisition of CBNA Undertaking and CFIL Undertaking will help strengthen Axis Bank's retail banking franchise and accelerate Axis Bank's growth ambitions across various consumer banking segments.

5.

Brief details of any governmental or regulatory approvals required for the acquisition

1. CBNA Undertaking - In terms of government or regulatory approvals, the transaction is subject to approval from the Competition Commission of India. Additionally, approval from other governmental authorities may be required for certain transitional services.

 

2. CFIL Undertaking - In terms of government or regulatory approvals, the transaction is subject to approval from the Competition Commission of India. Additionally, approval from other governmental authorities may be required for certain transitional services.

 

In addition to the above, the parties will undertake continuous consultations with the Reserve Bank of India and other relevant governmental authorities as may be required for the implementation of the transactions.

6.

Indicative time period for completion of the acquisition

Subject to the satisfactory completion of the customary and contractual conditions in accordance with the provisions of the CBNA BTA and CFIL BTA, respectively, the transactions are currently anticipated to be completed within 12 months or such other date as may be mutually agreed.

7.

Nature of consideration - whether cash consideration or share swap and details of the same

1. CBNA Undertaking - The entire consideration will be discharged by Axis Bank only in cash.

2. CFIL Undertaking - The entire consideration will be discharged by Axis Bank only in cash.

8.

Cost of acquisition or the price at which the shares are acquired

No shares are being acquired pursuant to the proposed transaction. The cost of acquisition of the CBNA Undertaking and the CFIL Undertaking is INR 12,325 crores.

9.

Percentage of shareholding / control acquired and / or number of shares acquired

Not applicable as no shares are being acquired pursuant to the proposed transaction. The transactions are proposed to be consummated as going concern, without values being assigned to individual assets and liabilities to either business.

10.

Brief background about the entity acquired in terms of products/line of business acquired, date of incorporation, history of last 3 years turnover, country in which the acquired entity has presence and any other significant information (in brief)

1. CBNA Undertaking - CBNA is the consumer division of financial services multinational Citigroup. CBNA was founded in 1812 as the City Bank of New York, and later became First National City Bank of New York. CBNA began operations in India over a century ago in 1902 in Kolkata. The amount of CBNA's gross revenue in India for the last three financial years is as below[3]:

· FY 18-19: INR 15,23,784 Lacs;

· FY 19-20: INR 17,70,195 Lacs; and

· FY 20-21: INR 16,15,019 Lacs.

 

2. CFIL Undertaking - CFIL is Citigroup's flagship non-banking finance entity. It was incorporated on May 1, 1997 in India. The amount of CFIL's gross revenue, on a standalone basis, for the last three financial years is as below[4]:

· FY 18-19: INR 96,368 Lacs;

· FY 19-20: INR 83,994 Lacs; and

· FY 20-21: INR 77,933 Lacs.

 

http://www.rns-pdf.londonstockexchange.com/rns/6260G_1-2022-3-30.pdf

 

[1] This figure represents the total income, i.e., interest earned and other income for Citibank N.A, India Branch, as a whole (which includes the CBNA Undertaking as well as other business lines of Citibank N.A., India Branch), as per its audited financials for FY 2021, and is not representative of the gross revenue of the CBNA Undertaking.

 

[2] This figure represents the total income, i.e., interest earned and other income for CFIL, as a whole (which includes the CFIL Undertaking as well as other business lines of CFIL), as per its audited financials for FY 2021, and is not representative of the gross revenue of the CFIL Undertaking.

[3] This figure represents the total income, i.e., interest earned and other income for Citibank N.A, India Branch, as a whole (which includes the CBNA Undertaking as well as other business lines of Citibank N.A., India Branch), as per its audited financials for FY 2019, FY 2020 and FY 2021, and is not representative of the gross revenue of the CBNA Undertaking.

 

[4] This figure represents the total income, i.e., interest earned and other income for CFIL, as a whole (which includes the CFIL Undertaking as well as other business lines of CFIL), as per its audited financials for FY 2019, FY 2020 and FY 2021, and is not representative of the gross revenue of the CFIL Undertaking.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJMMBTMTAJBTT
Date   Source Headline
10th May 20245:00 pmRNSCredit Rating - Fitch Ratings
10th May 20244:35 pmRNSResults of Postal Ballot
25th Apr 20241:41 pmRNSOutcome of Board Meeting
25th Apr 20247:43 amRNSGrant of Stock Options/Units
25th Apr 20247:38 amRNSRe-appointment of Directors
24th Apr 202412:52 pmRNSOutcome of Board Meeting
24th Apr 202412:45 pmRNSFinancial Results
19th Apr 202410:39 amRNSAppointment of Joint Statutory Auditors
18th Apr 20242:39 pmRNSBoard Meeting Intimation
18th Apr 20247:00 amRNSUpdate on Acquisition
10th Apr 20249:49 amRNSPostal Ballot Notice dated April 4, 2024
3rd Apr 202412:09 pmRNSUpdate on Acquisition
14th Mar 20247:00 amRNSChanges in Senior Management
7th Mar 20249:29 amRNSAllotment of Non Convertible Debentures
1st Mar 20245:01 pmRNSIssuance of Non Convertible Debentures
27th Feb 20242:07 pmRNSAppointment of Executive Director
21st Feb 20241:25 pmRNSCredit Rating
14th Feb 202412:39 pmRNSAppointment of Additional Independent Director
24th Jan 202410:49 amRNSOutcome of Board Meeting - 24012024
23rd Jan 202412:01 pmRNSInvestor Presentation and Press Release
23rd Jan 202411:46 amRNSOutcome of Board Meeting
18th Jan 20242:15 pmRNSCessation
3rd Jan 20243:11 pmRNSBoard Meeting Intimation
1st Dec 20231:52 pmRNSPostal Ballot Results
22nd Nov 20232:22 pmRNSCredit Rating - ICRA
17th Nov 20237:00 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
26th Oct 202312:56 pmRNSAppointment of Whole Time Director
25th Oct 202312:40 pmRNSRelated Party Transaction
25th Oct 202312:18 pmRNSInvestor Presentation and Press Release
25th Oct 202312:02 pmRNSOutcome of Board Meeting 25102023
17th Oct 202310:00 amRNSCredit Rating
6th Oct 20231:25 pmRNSBoard Meeting Intimation 25102023
3rd Oct 20233:00 pmRNSCredit Rating
26th Sep 202312:46 pmRNSPostal Ballot Notice
13th Sep 202310:07 amRNSDisclosure under Reg 30 of SEBI (LODR) Reg. 2015
17th Aug 20234:46 pmRNSRBI Approval for appointment of Subrat Mohanty
9th Aug 20231:45 pmRNSDisclosure under Reg 30 of SEBI (LODR) Regulations
9th Aug 202312:36 pmRNSDisclosure Under Reg 30 of SEBI (LODR) Reg, 2015
1st Aug 20234:58 pmRNSResignation of Independent Director
27th Jul 20231:54 pmRNSOutcome of Board meeting
27th Jul 202310:47 amRNSAppointment
26th Jul 202312:50 pmRNSInvestor Presentation and Press Release
26th Jul 202312:44 pmRNSOutcome of Board Meeting 26072023
17th Jul 20235:23 pmRNSReclassification of Promoter
27th Jun 20234:12 pmRNSCredit Rating
26th Jun 202312:09 pmRNSNotice of Annual General Meeting and Annual Report
16th Jun 20231:53 pmRNSAppointment of Non-Executive (Part-time) Chairman
30th May 20233:44 pmRNSIntimation of Record date for Dividend
30th May 20233:30 pmRNSAppointment of Additional Independent Director
4th May 20231:49 pmRNSReclassification of Promoter

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.